Lattice
-
Financial
Lattice Biologics Completes $500k Private Placement Announced on June 28, 2016
SCOTTSDALE, AZ–(Marketwired – August 08, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (“Lattice Biologics” or the “Company“) is…
Read More » -
Top Stories
MAJOR SOUTHWEST HOSPITAL GROUP DESIGNATES LATTICE BIOLOGICS AS APPROVED VENDOR
June 9, 2016 – Scottsdale, AZ – Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: BLVKF) (the “Company”) announced today that it…
Read More » -
Lattice Q2 Results Call Recap: catch up on biologics products, research efforts, financials, distribution, and team member updates
Written by: Cheryl Farmer On Friday, May 27th, 2016, the Lattice Biologics team enjoyed the opportunity to share the…
Read More » -
Notice of Lattice Biologics Ltd. Second Quarter 2016 Financial Results Conference Call
SCOTTSDALE, AZ–(Marketwired – May 20, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (the “Company”) announced today it will release…
Read More » -
Lattice Biologics Preparing to Launch Three New Products Featuring Matrix-Assisted Regeneration (MAR) Technology
SCOTTSDALE, AZ–(Marketwired – April 18, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) (Lattice Biologics) to launch three new…
Read More » -
Lattice Biologics Offering Exclusive Access to Revolutionary High-Throughput Precision Chemotherapy Screening for Breast Cancer
SCOTTSDALE, AZ–(Marketwired – April 15, 2016) – Lattice Biologics Ltd. (TSX VENTURE:LBL) (OTCBB: BLVKF) is offering select breast reconstruction surgeons…
Read More » -
Financial
Lattice Biologics First Quarter 2016 Highlights
Lattice Biologics Ltd. (TSX VENTURE: LBL)(“Lattice Biologics” or the “Company”) announces financial results for the first quarter ended December 31,…
Read More » -
Biologics
Lattice Biologics is going Public! Merger with Blackstone Ventures
August 13, 2015 – Lattice Biologics Inc. (“Lattice”) is pleased to announce that it has entered into a letter of…
Read More »